Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Safety and Tolerability of PF-05230907 in Intracerebral Hemorrhage
A Phase 1b Multicenter, Open-label Study To Evaluate The Safety And Tolerability And Determine The Maximum Tolerated Dose Of Pf-05230907 In Subjects With Intracerebral Hemorrhage (Ich)
Status: Enrolling
Updated:  2/9/2018
Ohio State University Medical Center
mi
from
Columbus, OH
Safety and Tolerability of PF-05230907 in Intracerebral Hemorrhage
A Phase 1b Multicenter, Open-label Study To Evaluate The Safety And Tolerability And Determine The Maximum Tolerated Dose Of Pf-05230907 In Subjects With Intracerebral Hemorrhage (Ich)
Status: Enrolling
Updated: 2/9/2018
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Safety and Tolerability of PF-05230907 in Intracerebral Hemorrhage
A Phase 1b Multicenter, Open-label Study To Evaluate The Safety And Tolerability And Determine The Maximum Tolerated Dose Of Pf-05230907 In Subjects With Intracerebral Hemorrhage (Ich)
Status: Enrolling
Updated:  2/9/2018
Martha Morehouse Medical Plaza
mi
from
Columbus, OH
Safety and Tolerability of PF-05230907 in Intracerebral Hemorrhage
A Phase 1b Multicenter, Open-label Study To Evaluate The Safety And Tolerability And Determine The Maximum Tolerated Dose Of Pf-05230907 In Subjects With Intracerebral Hemorrhage (Ich)
Status: Enrolling
Updated: 2/9/2018
Martha Morehouse Medical Plaza
mi
from
Columbus, OH
Click here to add this to my saved trials
Safety and Tolerability of PF-05230907 in Intracerebral Hemorrhage
A Phase 1b Multicenter, Open-label Study To Evaluate The Safety And Tolerability And Determine The Maximum Tolerated Dose Of Pf-05230907 In Subjects With Intracerebral Hemorrhage (Ich)
Status: Enrolling
Updated:  2/9/2018
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Safety and Tolerability of PF-05230907 in Intracerebral Hemorrhage
A Phase 1b Multicenter, Open-label Study To Evaluate The Safety And Tolerability And Determine The Maximum Tolerated Dose Of Pf-05230907 In Subjects With Intracerebral Hemorrhage (Ich)
Status: Enrolling
Updated: 2/9/2018
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Safety and Tolerability of PF-05230907 in Intracerebral Hemorrhage
A Phase 1b Multicenter, Open-label Study To Evaluate The Safety And Tolerability And Determine The Maximum Tolerated Dose Of Pf-05230907 In Subjects With Intracerebral Hemorrhage (Ich)
Status: Enrolling
Updated:  2/9/2018
Washington University
mi
from
Saint Louis, MO
Safety and Tolerability of PF-05230907 in Intracerebral Hemorrhage
A Phase 1b Multicenter, Open-label Study To Evaluate The Safety And Tolerability And Determine The Maximum Tolerated Dose Of Pf-05230907 In Subjects With Intracerebral Hemorrhage (Ich)
Status: Enrolling
Updated: 2/9/2018
Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Safety and Tolerability of PF-05230907 in Intracerebral Hemorrhage
A Phase 1b Multicenter, Open-label Study To Evaluate The Safety And Tolerability And Determine The Maximum Tolerated Dose Of Pf-05230907 In Subjects With Intracerebral Hemorrhage (Ich)
Status: Enrolling
Updated:  2/9/2018
The Ottawa Hospital
mi
from
Ottawa,
Safety and Tolerability of PF-05230907 in Intracerebral Hemorrhage
A Phase 1b Multicenter, Open-label Study To Evaluate The Safety And Tolerability And Determine The Maximum Tolerated Dose Of Pf-05230907 In Subjects With Intracerebral Hemorrhage (Ich)
Status: Enrolling
Updated: 2/9/2018
The Ottawa Hospital
mi
from
Ottawa,
Click here to add this to my saved trials
Maternal Oral Therapy to Reduce Obstetric Risk Kids
Maternal Oral Therapy to Reduce Obstetric Risk Kids
Status: Enrolling
Updated:  2/12/2018
University of Alabama at Birmingham Department of Ostetrics and Gynecology
mi
from
Birmingham, AL
Maternal Oral Therapy to Reduce Obstetric Risk Kids
Maternal Oral Therapy to Reduce Obstetric Risk Kids
Status: Enrolling
Updated: 2/12/2018
University of Alabama at Birmingham Department of Ostetrics and Gynecology
mi
from
Birmingham, AL
Click here to add this to my saved trials
Maternal Oral Therapy to Reduce Obstetric Risk Kids
Maternal Oral Therapy to Reduce Obstetric Risk Kids
Status: Enrolling
Updated:  2/12/2018
Department of Periodontology, UNC School of Dentistry
mi
from
Chapel Hill, NC
Maternal Oral Therapy to Reduce Obstetric Risk Kids
Maternal Oral Therapy to Reduce Obstetric Risk Kids
Status: Enrolling
Updated: 2/12/2018
Department of Periodontology, UNC School of Dentistry
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Maternal Oral Therapy to Reduce Obstetric Risk Kids
Maternal Oral Therapy to Reduce Obstetric Risk Kids
Status: Enrolling
Updated:  2/12/2018
Duke University
mi
from
Durham, NC
Maternal Oral Therapy to Reduce Obstetric Risk Kids
Maternal Oral Therapy to Reduce Obstetric Risk Kids
Status: Enrolling
Updated: 2/12/2018
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Maternal Oral Therapy to Reduce Obstetric Risk Kids
Maternal Oral Therapy to Reduce Obstetric Risk Kids
Status: Enrolling
Updated:  2/12/2018
University of Texas Health Science Center
mi
from
San Antonio, TX
Maternal Oral Therapy to Reduce Obstetric Risk Kids
Maternal Oral Therapy to Reduce Obstetric Risk Kids
Status: Enrolling
Updated: 2/12/2018
University of Texas Health Science Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
SUNCIST: A Study of Calmangafodipir in Healthy Japanese and Caucasian Subjects
SUNCIST: A Phase I, Randomized, Double-Blind, Placebo-Controlled, Ascending, Single-Dose Study to Assess the Safety, Tolerability, Pharmacokinetics of Intravenous Administration of Calmangafodipir in Healthy Japanese and Caucasian Subjects
Status: Enrolling
Updated:  2/12/2018
Wcct Global, Llc
mi
from
Cypress, CA
SUNCIST: A Study of Calmangafodipir in Healthy Japanese and Caucasian Subjects
SUNCIST: A Phase I, Randomized, Double-Blind, Placebo-Controlled, Ascending, Single-Dose Study to Assess the Safety, Tolerability, Pharmacokinetics of Intravenous Administration of Calmangafodipir in Healthy Japanese and Caucasian Subjects
Status: Enrolling
Updated: 2/12/2018
Wcct Global, Llc
mi
from
Cypress, CA
Click here to add this to my saved trials
The Effects of Repetitive Paired Associative Stimulation in Dystonia
Investigating the Plastic Effects of Repetitive Paired Associative Stimulation (rPAS) in Dystonia
Status: Enrolling
Updated:  2/13/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
The Effects of Repetitive Paired Associative Stimulation in Dystonia
Investigating the Plastic Effects of Repetitive Paired Associative Stimulation (rPAS) in Dystonia
Status: Enrolling
Updated: 2/13/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Arrhythmias in Myotonic Muscular Dystrophy
A Registry of Arrhythmias in Myotonic Muscular Dystrophy
Status: Enrolling
Updated:  2/13/2018
Krannert Institute of Cardiology
mi
from
Indianapolis, IN
Arrhythmias in Myotonic Muscular Dystrophy
A Registry of Arrhythmias in Myotonic Muscular Dystrophy
Status: Enrolling
Updated: 2/13/2018
Krannert Institute of Cardiology
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Mirror Therapy After Stroke: A Dosing Study
Self-directed Box (Mirror) Therapy After Stroke: A Dosing Study
Status: Enrolling
Updated:  2/13/2018
Helen Hayes Hospital (Stroke Unit)
mi
from
West Haverstraw, NY
Mirror Therapy After Stroke: A Dosing Study
Self-directed Box (Mirror) Therapy After Stroke: A Dosing Study
Status: Enrolling
Updated: 2/13/2018
Helen Hayes Hospital (Stroke Unit)
mi
from
West Haverstraw, NY
Click here to add this to my saved trials
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated:  2/13/2018
US106
mi
from
Columbus, OH
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated: 2/13/2018
US106
mi
from
Columbus, OH
Click here to add this to my saved trials
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated:  2/13/2018
US133
mi
from
Rancho Mirage, CA
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated: 2/13/2018
US133
mi
from
Rancho Mirage, CA
Click here to add this to my saved trials
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated:  2/13/2018
US104
mi
from
Boca Raton, FL
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated: 2/13/2018
US104
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated:  2/13/2018
US122
mi
from
Orlando, FL
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated: 2/13/2018
US122
mi
from
Orlando, FL
Click here to add this to my saved trials
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated:  2/13/2018
US118
mi
from
Indianapolis, IN
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated: 2/13/2018
US118
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated:  2/13/2018
US100
mi
from
Chapel Hill, NC
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated: 2/13/2018
US100
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated:  2/13/2018
US131
mi
from
Portland, OR
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated: 2/13/2018
US131
mi
from
Portland, OR
Click here to add this to my saved trials
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated:  2/13/2018
US138
mi
from
Phoenix, AZ
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated: 2/13/2018
US138
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated:  2/13/2018
US139
mi
from
Sun City, AZ
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated: 2/13/2018
US139
mi
from
Sun City, AZ
Click here to add this to my saved trials
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated:  2/13/2018
US125
mi
from
Tucson, AZ
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated: 2/13/2018
US125
mi
from
Tucson, AZ
Click here to add this to my saved trials
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated:  2/13/2018
US119
mi
from
Orange, CA
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated: 2/13/2018
US119
mi
from
Orange, CA
Click here to add this to my saved trials
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated:  2/13/2018
US134
mi
from
Oxnard, CA
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated: 2/13/2018
US134
mi
from
Oxnard, CA
Click here to add this to my saved trials
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated:  2/13/2018
US141
mi
from
Englewood, CO
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated: 2/13/2018
US141
mi
from
Englewood, CO
Click here to add this to my saved trials
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated:  2/13/2018
US111
mi
from
Jacksonville, FL
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated: 2/13/2018
US111
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated:  2/13/2018
US137
mi
from
Palm Beach Gardens, FL
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated: 2/13/2018
US137
mi
from
Palm Beach Gardens, FL
Click here to add this to my saved trials
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated:  2/13/2018
US126
mi
from
Tampa, FL
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated: 2/13/2018
US126
mi
from
Tampa, FL
Click here to add this to my saved trials
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated:  2/13/2018
US136
mi
from
Atlanta, GA
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated: 2/13/2018
US136
mi
from
Atlanta, GA
Click here to add this to my saved trials
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated:  2/13/2018
US130
mi
from
Quincy, MA
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated: 2/13/2018
US130
mi
from
Quincy, MA
Click here to add this to my saved trials
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated:  2/13/2018
US102
mi
from
Rochester, MN
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated: 2/13/2018
US102
mi
from
Rochester, MN
Click here to add this to my saved trials
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated:  2/13/2018
US110
mi
from
Cleveland, OH
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated: 2/13/2018
US110
mi
from
Cleveland, OH
Click here to add this to my saved trials
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated:  2/13/2018
US120
mi
from
Willow Grove, PA
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated: 2/13/2018
US120
mi
from
Willow Grove, PA
Click here to add this to my saved trials
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated:  2/13/2018
US101
mi
from
Charlottesville, VA
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated: 2/13/2018
US101
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated:  2/13/2018
CA200
mi
from
Toronto,
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated: 2/13/2018
CA200
mi
from
Toronto,
Click here to add this to my saved trials
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated:  2/13/2018
US108
mi
from
Phoenix, AZ
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated: 2/13/2018
US108
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated:  2/13/2018
US140
mi
from
Sacramento, CA
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated: 2/13/2018
US140
mi
from
Sacramento, CA
Click here to add this to my saved trials
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated:  2/13/2018
US105
mi
from
Lexington, KY
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated: 2/13/2018
US105
mi
from
Lexington, KY
Click here to add this to my saved trials
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated:  2/13/2018
US109
mi
from
New York, NY
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated: 2/13/2018
US109
mi
from
New York, NY
Click here to add this to my saved trials
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated:  2/13/2018
US123
mi
from
Washington,
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Status: Enrolling
Updated: 2/13/2018
US123
mi
from
Washington,
Click here to add this to my saved trials
A Study of Oxytocin for the Treatment of Social Impairment in Individuals With High Functioning Autism Spectrum Disorder
A Pilot Study of Oxytocin for the Treatment of Social Impairment in Individuals With High Functioning Autism Spectrum Disorder
Status: Enrolling
Updated:  2/13/2018
Massachusetts General Hospital
mi
from
Boston, MA
A Study of Oxytocin for the Treatment of Social Impairment in Individuals With High Functioning Autism Spectrum Disorder
A Pilot Study of Oxytocin for the Treatment of Social Impairment in Individuals With High Functioning Autism Spectrum Disorder
Status: Enrolling
Updated: 2/13/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
The Effect of Nebulized Albuterol on Donor Oxygenation
The Effect of Nebulized Albuterol on Donor Oxygenation
Status: Enrolling
Updated:  2/14/2018
California Transplant Donor Network
mi
from
Oakland, CA
The Effect of Nebulized Albuterol on Donor Oxygenation
The Effect of Nebulized Albuterol on Donor Oxygenation
Status: Enrolling
Updated: 2/14/2018
California Transplant Donor Network
mi
from
Oakland, CA
Click here to add this to my saved trials
The Spot Sign for Predicting and Treating ICH Growth Study
The Spot Sign for Predicting and Treating Intracerebral Hemorrhage Growth Study
Status: Enrolling
Updated:  2/14/2018
St. Joseph's Hospital and Medical Center
mi
from
Phoenix, AZ
The Spot Sign for Predicting and Treating ICH Growth Study
The Spot Sign for Predicting and Treating Intracerebral Hemorrhage Growth Study
Status: Enrolling
Updated: 2/14/2018
St. Joseph's Hospital and Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
The Spot Sign for Predicting and Treating ICH Growth Study
The Spot Sign for Predicting and Treating Intracerebral Hemorrhage Growth Study
Status: Enrolling
Updated:  2/14/2018
Massachusetts General Hospital
mi
from
Boston, MA
The Spot Sign for Predicting and Treating ICH Growth Study
The Spot Sign for Predicting and Treating Intracerebral Hemorrhage Growth Study
Status: Enrolling
Updated: 2/14/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
The Spot Sign for Predicting and Treating ICH Growth Study
The Spot Sign for Predicting and Treating Intracerebral Hemorrhage Growth Study
Status: Enrolling
Updated:  2/14/2018
University of Cincinnati—Clinical Coordinating Center
mi
from
Cincinnati, OH
The Spot Sign for Predicting and Treating ICH Growth Study
The Spot Sign for Predicting and Treating Intracerebral Hemorrhage Growth Study
Status: Enrolling
Updated: 2/14/2018
University of Cincinnati—Clinical Coordinating Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
The Spot Sign for Predicting and Treating ICH Growth Study
The Spot Sign for Predicting and Treating Intracerebral Hemorrhage Growth Study
Status: Enrolling
Updated:  2/14/2018
Univ of Pennsylvania
mi
from
Philadelphia, PA
The Spot Sign for Predicting and Treating ICH Growth Study
The Spot Sign for Predicting and Treating Intracerebral Hemorrhage Growth Study
Status: Enrolling
Updated: 2/14/2018
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
The Spot Sign for Predicting and Treating ICH Growth Study
The Spot Sign for Predicting and Treating Intracerebral Hemorrhage Growth Study
Status: Enrolling
Updated:  2/14/2018
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
The Spot Sign for Predicting and Treating ICH Growth Study
The Spot Sign for Predicting and Treating Intracerebral Hemorrhage Growth Study
Status: Enrolling
Updated: 2/14/2018
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
The Spot Sign for Predicting and Treating ICH Growth Study
The Spot Sign for Predicting and Treating Intracerebral Hemorrhage Growth Study
Status: Enrolling
Updated:  2/14/2018
Medical University of South Carolina
mi
from
Charleston, SC
The Spot Sign for Predicting and Treating ICH Growth Study
The Spot Sign for Predicting and Treating Intracerebral Hemorrhage Growth Study
Status: Enrolling
Updated: 2/14/2018
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
The Spot Sign for Predicting and Treating ICH Growth Study
The Spot Sign for Predicting and Treating Intracerebral Hemorrhage Growth Study
Status: Enrolling
Updated:  2/14/2018
University of California, San Diego
mi
from
San Diego, CA
The Spot Sign for Predicting and Treating ICH Growth Study
The Spot Sign for Predicting and Treating Intracerebral Hemorrhage Growth Study
Status: Enrolling
Updated: 2/14/2018
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials